Hedge Fund - Harbert Management
Enzo Biochem Inc (ENZ)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q2 (2024-06-30) | $5,641,745 | 4% | 5,175,913 | $1.13 |
2 | 2024 - Q1 (2024-03-31) | $6,573,409 | 4.52% | 5,175,913 | $1.32 |
3 | 2023 - Q4 (2023-12-31) | $7,194,519 | 4.93% | 5,175,913 | $1.33 |
4 | 2023 - Q3 (2023-09-30) | $7,246,278 | 5.16% | 5,175,913 | $1.51 |
5 | 2023 - Q2 (2023-06-30) | $9,523,680 | 5.33% | 5,175,913 | $2.31 |
6 | 2023 - Q1 (2023-03-31) | $12,577,469 | 8.31% | 5,175,913 | $1.49 |
7 | 2022 - Q4 (2022-12-31) | $7,401,556 | 5.92% | 5,175,913 | $1.95 |
8 | 2022 - Q3 (2022-09-30) | $11,542,000 | 6.12% | 5,175,913 | $2.42 |
9 | 2022 - Q2 (2022-06-30) | $10,714,000 | 5.21% | 5,175,913 | $2.47 |
10 | 2022 - Q1 (2022-03-31) | $15,010,000 | 6.29% | 5,175,913 | $3.21 |
11 | 2021 - Q4 (2021-12-31) | $16,615,000 | 4.18% | 5,175,913 | $3.41 |
12 | 2021 - Q3 (2021-09-30) | $18,323,000 | 6.5% | 5,175,913 | $3.34 |
13 | 2021 - Q2 (2021-06-30) | $16,407,000 | 9.15% | 5,175,913 | $3.15 |
14 | 2021 - Q1 (2021-03-31) | $17,805,000 | 8.4% | 5,175,913 | $3.11 |
15 | 2020 - Q4 (2020-12-31) | $14,164,000 | 10.72% | 5,620,681 | $2.18 |
16 | 2020 - Q3 (2020-09-30) | $11,860,000 | 14.49% | 5,620,681 | $2.38 |
17 | 2020 - Q2 (2020-06-30) | $12,591,000 | 14.33% | 5,620,681 | $2.57 |
18 | 2020 - Q1 (2020-03-31) | $14,220,000 | 23.77% | 5,620,681 | $2.46 |
19 | 2019 - Q4 (2019-12-31) | $14,782,000 | 19.75% | 5,620,681 | $2.99 |
20 | 2019 - Q3 (2019-09-30) | $20,234,000 | 30.1% | 5,620,681 | $3.54 |
21 | 2019 - Q2 (2019-06-30) | $17,420,000 | 25.48% | 5,169,337 | $3.52 |
22 | 2019 - Q1 (2019-03-31) | $8,281,000 | 8.14% | 3,033,641 | $3.27 |
23 | 2018 - Q4 (2018-12-31) | $4,461,000 | 4.55% | 1,605,000 | $3.28 |
The displayed share prices are average quarterly stock market prices.